Efficacy testing of antimycotic prophylactics in an animal model

A Treiber1, W Pittermann, H C Schuppe

  • 1Universitätsklinikum Düsseldorf, Tierversuchsanlage, Moorenstrasse 5, D-40225 Düsseldorf, Germany. treiber@uni-duesseldorf.de

Insights

This study refines a guinea pig model for testing antifungal drugs against Trichophyton mentagrophytes, a common cause of human skin infections. The improved model allows for statistical analysis of treatment efficacy.

Area of Science:

  • Mycology
  • Dermatology
  • Pharmacology

Background:

  • Trichophyton mentagrophytes is a significant zoophilic dermatophyte causing human dermatomycosis.
  • Guinea pigs are a suitable animal model for dermatomycosis due to their susceptibility to spontaneous fungal infections.
  • Existing models require refinement for reproducible and statistically valid efficacy testing of antimycotic agents.

Purpose of the Study:

  • To modify and validate a guinea pig model for assessing the efficacy of antimycotic agents against Trichophyton mentagrophytes.
  • To establish standardized methods for infection induction and clinical observation.
  • To enable statistically sound evaluation of treatment outcomes.

Main Methods:

  • Modification of a previously described guinea pig model.
  • Infection of animals with primary mycotic tissue cultures of T. mentagrophytes.
  • Treatment groups included infection control, negative control (isopropanol), mechanical control (water), and antimycotic agent.
  • 28-day continuous clinical observation and statistical analysis of symptoms (scabs, redness, scaliness).

Main Results:

  • The modified protocol determined optimal cultivation duration and spore counts for reproducible infection.
  • Statistical analysis of clinical symptoms demonstrated significant differences between treatment groups.
  • The model successfully evaluated the prophylactic efficacy of Laudamonium (1%) against T. mentagrophytes.

Conclusions:

  • The presented experimental protocol provides a statistically valid method for demonstrating the efficacy of antimycotic agents.
  • The refined guinea pig model is effective for screening and validating new antifungal treatments.
  • This model aids in the development of new therapies for dermatomycosis caused by T. mentagrophytes.